News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
127,145 Results
Type
Article (4268)
Company Profile (94)
Press Release (122783)
Section
Business (42049)
Career Advice (208)
Deals (6150)
Drug Delivery (13)
Drug Development (17410)
Employer Resources (18)
FDA (1489)
Job Trends (2771)
News (66157)
Policy (3648)
Tag
Academia (286)
Alliances (11393)
Alzheimer's disease (286)
Approvals (1486)
Artificial intelligence (24)
Bankruptcy (37)
Best Places to Work (2230)
Biotechnology (90)
Breast cancer (50)
Cancer (343)
Career advice (195)
CAR-T (31)
Cell therapy (111)
Clinical research (13751)
Collaboration (157)
Compensation (51)
COVID-19 (423)
C-suite (52)
Cystic fibrosis (21)
Data (387)
Diabetes (32)
Diagnostics (671)
Drug discovery (31)
Earnings (12161)
Events (24076)
Executive appointments (151)
FDA (1614)
Funding (125)
Gene therapy (49)
GLP-1 (97)
Government (341)
Healthcare (1497)
Infectious disease (442)
Inflammatory bowel disease (41)
IPO (2902)
Job creations (665)
Job search strategy (184)
Layoffs (33)
Legal (634)
Lymphoma (32)
Manufacturing (59)
Medical device (391)
Medtech (391)
Mergers & acquisitions (3358)
Metabolic disorders (80)
Neuroscience (363)
NextGen Class of 2024 (853)
Non-profit (269)
Northern California (541)
Obesity (44)
Opinion (37)
Parkinson's disease (28)
Patents (30)
People (16151)
Phase I (5454)
Phase II (6557)
Phase III (3378)
Pipeline (144)
Policy (22)
Postmarket research (209)
Preclinical (2349)
Press Release (51)
Radiopharmaceuticals (44)
Rare diseases (50)
Real estate (1440)
Regulatory (2868)
Research institute (298)
Resumes & cover letters (20)
Series A (19)
Southern California (486)
Startups (981)
United States (4138)
Vaccines (54)
Date
Today (3)
Last 7 days (142)
Last 30 days (656)
Last 365 days (9178)
2024 (9146)
2023 (9880)
2022 (12009)
2021 (12663)
2020 (9869)
2019 (6673)
2018 (5275)
2017 (6073)
2016 (5598)
2015 (6441)
2014 (4927)
2013 (4063)
2012 (4397)
2011 (4873)
2010 (4518)
Location
Africa (135)
Alabama (22)
Asia (8364)
Australia (1965)
California (1213)
Canada (405)
China (69)
Connecticut (45)
Europe (18135)
Florida (105)
Georgia (20)
Illinois (99)
Indiana (69)
Maryland (139)
Massachusetts (879)
Michigan (58)
Minnesota (71)
New Jersey (298)
New York (292)
North Carolina (191)
Northern California (541)
Ohio (26)
Pennsylvania (260)
South America (198)
Southern California (486)
Texas (130)
Washington State (246)
127,145 Results for "lfb biotechnologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
LFB Plasma Joins Plasma Protein Therapeutics Association (PPTA)
LFB Plasma, a US-based plasma collection company and subsidiary of the LFB Group, a leading European company providing plasma-derived products to healthcare professionals, announces joining the Plasma Protein Therapeutics Association.
September 9, 2022
·
2 min read
Layoffs
Sana Biotechnology Will Lay Off Employees as It Shifts Pipeline
About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 diabetes program and looks to extend its cash runway.
November 5, 2024
·
1 min read
·
Angela Gabriel
LFB Announces the Approval of CEVENFACTA® (eptacog beta) in the European Union
LFB today announced that the European Medicines Agency (EMA) has granted on July 15th a Marketing Authorisation for CEVENFACTA® (eptacog beta), as the first new bypassing agent in over 20 years.
July 25, 2022
·
5 min read
Press Releases
Altimmune Added to Nasdaq Biotechnology Index
December 19, 2024
·
2 min read
Press Releases
Mesoblast to be Added to Nasdaq Biotechnology Index
December 19, 2024
·
5 min read
Press Releases
MindMed to Be Added to the Nasdaq Biotechnology Index
December 19, 2024
·
4 min read
Press Releases
Aramis Biotechnologies and Biodextris Announce Partnership
December 17, 2024
·
2 min read
Press Releases
Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation
December 23, 2024
·
8 min read
Press Releases
Solid Biosciences Added to the Nasdaq Biotechnology Index
December 24, 2024
·
1 min read
Press Releases
CorMedix Inc. Added to Nasdaq Biotechnology Index
December 20, 2024
·
1 min read
1 of 12,715
Next